IMR Press / EJGO / Volume 30 / Issue 1 / pii/2009005

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Original Research

Radiation therapy in cervical carcinoma fifteen years experience in a Norwegian health region

Show Less
1 Department of Gynaecological Oncology, St. Olavs Hospital/University Hospital, Trondheim (Norway)
2 Deparment of Oncology and Radiotherapy, St. Olavs Hospital/University Hospital, Trondheim (Norway)
Eur. J. Gynaecol. Oncol. 2009, 30(1), 20–24;
Published: 10 February 2009

Background: To study the treatment of patients with cervical carcinoma with regard to side effects and survival. Materials and Methods: A retrospective analysis of 107 patients with cervical carcinoma treated by radiotherapy with curative intent between January 1,1987 and December 31, 2001. Results: Median follow-up:139 months for surviving patients and 23 months for deceased patients. Five-year overall and disease-specific survival for all stages was 36% and 45%,respectively.Corresponding figures foreach stage were, Stage I: 54% and 80%,Stage II: 41% and 56%, Stage II: 33% and 36%o and Stage NV: <1%. Five-year actuarial incidence of late reactions, all grades were: vagina 77%, rectum 41%, urinary tract 28%, and gastrointestinal tract 37%. Interpretation: a great variation of treatment techniques resulted in an overall survival somewhat inferior to that in other comparable seres. Over time, an increasing tendency to include brachytherapy and external tumour boost was observed.

Cervical carcinoma
Radiation therapy
Late reactions
Back to top